Table of Contents
ISRN Hematology
Volume 2012, Article ID 971493, 7 pages
http://dx.doi.org/10.5402/2012/971493
Clinical Study

Evaluation of X-Chromosome Inactivation Patterns in Patients with Acute Myeloid Leukemia during Remission

1Department of Molecular Medicine, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan 4513956111, Iran
2Department of Hematology, Tarbiat Modares University, Tehran, Iran
3Hematology-Oncology and Bone Marrow Stem Cell Transplantation Research Center, Shariati Hospital, Tehran, Iran
4Department of Immunology, Tarbiat Modares University, Tehran, Iran
5Hormozgan University of Medical Sciences, Hormozgn, Iran

Received 25 August 2012; Accepted 22 September 2012

Academic Editors: A. Bosly and C. Panizo

Copyright © 2012 Yousef Mortazavi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. R. Migeon, “X-chromosome inactivation: molecular mechanisms and genetic consequences,” Trends in Genetics, vol. 10, no. 7, pp. 230–235, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. M. F. Lyon, “Gene action in the X-chromosome of the mouse (Mus musculus L.),” Nature, vol. 190, no. 4773, pp. 372–373, 1961. View at Publisher · View at Google Scholar · View at Scopus
  3. D. G. Gilliland, K. L. Blanchard, J. Levy, S. Perrin, and H. F. Bunn, “Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 15, pp. 6848–6852, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. R. E. Gale and D. C. Linch, “Clonality studies in acute myeloid leukemia,” Leukemia, vol. 12, no. 2, pp. 117–120, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. R. E. Gale, “Evaluation of clonality in myeloid stem-cell disorders,” Seminars in Hematology, vol. 36, no. 4, pp. 361–372, 1999. View at Google Scholar · View at Scopus
  6. E. Hodges, W. M. Howell, Y. Boyd, and J. L. Smith, “Variable X-chromosome DNA methylation patterns detected with probe M27β in a series of lymphoid and myeloid malignancies,” British Journal of Haematology, vol. 77, no. 3, pp. 315–322, 1991. View at Google Scholar · View at Scopus
  7. S. I. Swierczek, L. Piterkova, and J. Jelinek, “Methylation of AR locus does not always reflect X chromosome inactivation state,” Blood, vol. 119, pp. e100–e109, 2012. View at Google Scholar
  8. R. E. Gale, H. Wheadon, and D. C. Linch, “Assessment of X-chromosome inactivation patterns using the hypervariable probe M27β in normal hemopoietic cells and acute myeloid leukemic blasts,” Leukemia, vol. 6, no. 7, pp. 649–655, 1992. View at Google Scholar · View at Scopus
  9. M. Dhodapkar, J. Grill, and J. A. Lust, “Abnormal regional hypermethylation of the calcitonin gene in myelodysplastic syndromes,” Leukemia Research, vol. 19, no. 10, pp. 719–726, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Iravani, R. Dhat, and C. M. Price, “Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15(INK4B)) in childhood acute lymphoblastic leukemia,” Oncogene, vol. 15, no. 21, pp. 2609–2614, 1997. View at Google Scholar · View at Scopus
  11. J. P. J. Issa, S. B. Baylin, and J. G. Herman, “DNA methylation changes in hematologic malignancies: biologic and clinical implications,” Leukemia, vol. 11, no. 1, pp. s7–S11, 1997. View at Google Scholar · View at Scopus
  12. J. P. J. Issa, B. A. Zehnbauer, S. H. Kaufmann, M. A. Biel, and S. B. Baylin, “HIC1 hypermethylation is a late event in hematopoietic neoplasms,” Cancer Research, vol. 57, no. 9, pp. 1678–1681, 1997. View at Google Scholar · View at Scopus
  13. G.J . Roboz and L. Sung, Acute Myeloid Leukemia, chapter 16, American Society of Hematology-Self Assessment Program, 4th edition, 2010.
  14. G. J. Roboz and M. Guzman, “Acute myeloid leukemia stem cells: seek and destroy,” Expert Review of Hematology, vol. 2, no. 6, pp. 663–672, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. R. G. Wiggans, R. J. Jacobson, and P. J. Fialkow, “Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer,” Blood, vol. 52, no. 4, pp. 659–663, 1978. View at Google Scholar · View at Scopus
  16. P. J. Fialkow, J. W. Singer, and W. H. Raskind, “Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia,” New England Journal of Medicine, vol. 317, no. 8, pp. 468–473, 1987. View at Google Scholar · View at Scopus
  17. P. J. Fialkow, S. M. Gartler, and A. Yoshida, “Clonal origin of chronic myelocyticleukemia in man,” Proceedings of the National Academy of Sciences of the Unites States of America, vol. 58, pp. 1468–1471, 1967. View at Google Scholar
  18. B. Anger, J. W. G. Janssen, H. Schrezenmeier, R. Hehlmann, H. Heimpel, and C. R. Bartram, “Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms,” Leukemia, vol. 4, no. 4, pp. 258–261, 1990. View at Google Scholar · View at Scopus
  19. N. El Kassar, G. Hetet, J. Brière, and B. Grandchamp, “X-chromosome inactivation in healthy females: incidence of excessive lyonization with age and comparison of assays involving DNA methylation and transcript polymorphisms,” Clinical Chemistry, vol. 44, no. 1, pp. 61–67, 1998. View at Google Scholar · View at Scopus
  20. M. Luhovy, Y. Liu, M. Belickova, J. F. Prchal, and J. T. Prchal, “A novel clonality assay based on transcriptional polymorphism of X chromosome gene p55,” Biology of Blood and Marrow Transplantation, vol. 1, no. 2, pp. 81–87, 1995. View at Google Scholar · View at Scopus
  21. J. J. Hopwood, S. Bunge, C. P. Morris et al., “Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene,” Human Mutation, vol. 2, no. 6, pp. 435–442, 1993. View at Google Scholar · View at Scopus
  22. Y. Mortazavi, R. Chopra, E. C. Gordon-Smith, and T. R. Rutherford, “Frequency of the G6PD nt 1311 C/T polymorphism in English and Iranian populations: relevance to studies of X chromosome inactivation,” Journal of Medical Genetics, vol. 34, no. 12, pp. 1028–1029, 1997. View at Google Scholar · View at Scopus
  23. N. El-Kassar, G. Hetet, J. Brière, and B. Grandchamp, “Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets,” Blood, vol. 89, no. 1, pp. 128–134, 1997. View at Google Scholar · View at Scopus
  24. Y. Mortazavi, R. Chopra, E. C. Gordon-Smith, and T. R. Rutherford, “Clonal patterns of X-chromosome inactivation in female patients with aplastic anaemia studied using a novel reverse transcription polymerase chain reaction method,” European Journal of Haematology, vol. 64, no. 6, pp. 385–395, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. P. J. Fialkow, “Use of genetic markers to study cellular originand development of tumors in human females,” Advances in Cancer Research, vol. 15, pp. 191–226, 1972. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Vogelstein, E. R. Fearon, S. R. Hamilton et al., “Clonal analysis using recombinant DNA probes from the X-chromosome,” Cancer Research, vol. 47, no. 18, pp. 4806–4813, 1987. View at Google Scholar · View at Scopus
  27. R. E. Gale, H. Wheadon, and D. C. Linch, “X-chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post-chemotherapy females,” British Journal of Haematology, vol. 79, no. 2, pp. 193–197, 1991. View at Google Scholar · View at Scopus
  28. J. T. Prchal, J. F. Prchal, M. Belickova et al., “Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism,” Journal of Experimental Medicine, vol. 183, no. 2, pp. 561–567, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Hodges, W. M. Howell, Y. Boyd, and J. L. Smith, “Variable X-chromosome DNA methylation patterns detected with probe M27β in a series of lymphoid and myeloid malignancies,” British Journal of Haematology, vol. 77, no. 3, pp. 315–322, 1991. View at Google Scholar · View at Scopus
  30. D. P. O'Malley, A. Orazi, M. Wang, and L. Cheng, “Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia,” Modern Pathology, vol. 18, no. 12, pp. 1562–1568, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. F. T. Keller, I. Sonnénburg, B. Stengel, W. Siegel, M. Sonnenburg, and J. Härtel, “Experimental animal studies on the possibilities of bone reconstruction using preserved allogenic material,” Zeitschrift fur Experimentelle Chirurgie Transplantation und Kunstliche Organe, vol. 23, no. 3, pp. 150–157, 1990. View at Google Scholar · View at Scopus
  32. L. Ding, T. J. Ley, D. E. Larson et al., “Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing,” Nature, vol. 481, no. 7382, pp. 506–510, 2012. View at Google Scholar
  33. I. Jinnai, K. Nagai, S. Yoshida et al., “Incidence and characteristics of clonal hematopoiesis in remission of acute myeloid leukemia in relation to morphological dysplasia,” Leukemia, vol. 9, no. 10, pp. 1756–1761, 1995. View at Google Scholar · View at Scopus
  34. J. L. Abkowitz, R. M. Ott, R. D. Holly, and J. W. Adamson, “Clonal evolution following chemotherapy-induced stem cell depletion in cats heterozygous for glucose-6-phosphate dehydrogenase,” Blood, vol. 71, no. 6, pp. 1687–1692, 1988. View at Google Scholar · View at Scopus